COVID-19-related science, data is still evolving. At this point, it’s not entirely clear whether the risk of blood clots differs between the first and second doses of the AstraZeneca COVID-19 vaccine.Experts believe it’s similarly rare, but it’s not impossible.“The risk remains, but it doesn’t seem to be higher when people take the second dose,” Dr.